BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kraińska MM, Pietrzkowska N, Turlej E, Zongjin L, Marycz K. Extracellular vesicles derived from mesenchymal stem cells as a potential therapeutic agent in acute kidney injury (AKI) in felines: review and perspectives. Stem Cell Res Ther 2021;12:504. [PMID: 34526105 DOI: 10.1186/s13287-021-02573-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang W, Zhang J, Huang H. Exosomes from adipose-derived stem cells inhibit inflammation and oxidative stress in LPS-acute kidney injury. Exp Cell Res 2022;420:113332. [PMID: 36084668 DOI: 10.1016/j.yexcr.2022.113332] [Reference Citation Analysis]
2 Abdolmohammadi K, Mahmoudi T, Alimohammadi M, Tahmasebi S, Zavvar M, Hashemi SM. Mesenchymal stem cell-based therapy as a new therapeutic approach for acute inflammatory diseases. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.121206] [Reference Citation Analysis]
3 Choi M, Yang YB, Park S, Rahaman S, Tripathi G, Lee BT. Effect of Co-culture of mesenchymal stem cell and glomerulus endothelial cell to promote endothelialization under optimized perfusion flow rate in whole renal ECM scaffold. Mater Today Bio 2022;17:100464. [PMID: 36325425 DOI: 10.1016/j.mtbio.2022.100464] [Reference Citation Analysis]
4 Arjmand B, Rabbani Z, Soveyzi F, Tayanloo-beik A, Rezaei-tavirani M, Biglar M, Adibi H, Larijani B. Advancement of Organoid Technology in Regenerative Medicine. Regen Eng Transl Med . [DOI: 10.1007/s40883-022-00271-0] [Reference Citation Analysis]
5 Stępień EŁ, Rząca C, Moskal P. Novel biomarker and drug delivery systems for theranostics – extracellular vesicles. Bio-Algorithms and Med-Systems 2022;17:301-9. [DOI: 10.1515/bams-2021-0183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]